Corona Therapeutics Candidate “Abigan” May 22 without application for approval this month 11:47
On a candidate for the new coronavirus drug, Abigan, Minister of Health, Labour and Welfare Kato stressed his intention to approve it later this month. However, since there are no applications from companies at this time, it is not possible to see if they will be approved by the end of this month.
Avigan is a new influenza drug developed by a Japanese pharmaceutical company, and clinical studies and clinical trials are being conducted in Japan to verify its efficacy and safety, and Prime Minister Shinzo Abe has indicated that he will seek approval later this month if the efficacy is confirmed.
At a press conference, Minister of Health, Labour and Welfare Kato made it clear that “in order to approve the pharmaceutical affairs, it is necessary to apply for approval from the company, but no application has been made at this time.”
On that basis, “If an application is made, the examination will be carried out as soon as necessary. If certain effects are confirmed, we are still firmly in our desire to approve it by the end of this month.”
Regarding Avigan, the Ministry of Health, Labour and Welfare has a policy of proceeding with a significantly shorter review than usual, but it is not possible to see whether it will be approved by the end of this month, depending on what kind of clinical trial data is submitted by the company.